Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Factors associated with poorer prognosis for patients undergoing primary percutaneous coronary intervention during off-hours: biology or systems failure?

Glaser R, Naidu SS, Selzer F, Jacobs AK, Laskey WK, Srinivas VS, Slater JN, Wilensky RL.

JACC Cardiovasc Interv. 2008 Dec;1(6):681-8. doi: 10.1016/j.jcin.2008.08.020.

2.

Off-hour primary percutaneous coronary angioplasty does not affect outcome of patients with ST-Segment elevation acute myocardial infarction treated within a regional network for reperfusion: The REAL (Registro Regionale Angioplastiche dell'Emilia-Romagna) registry.

Casella G, Ottani F, Ortolani P, Guastaroba P, Santarelli A, Balducelli M, Menozzi A, Magnavacchi P, Sangiorgi GM, Manari A, De Palma R, Marzocchi A.

JACC Cardiovasc Interv. 2011 Mar;4(3):270-8. doi: 10.1016/j.jcin.2010.11.012.

3.

Physicians ... wake up!

Shah AP, French WJ.

JACC Cardiovasc Interv. 2008 Dec;1(6):689-91. doi: 10.1016/j.jcin.2008.08.019. No abstract available.

4.

Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.

Pride YB, Canto JG, Frederick PD, Gibson CM; NRMI Investigators.

JACC Cardiovasc Interv. 2009 Oct;2(10):944-52. doi: 10.1016/j.jcin.2009.07.008.

5.

Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines).

Parikh SV, de Lemos JA, Jessen ME, Brilakis ES, Ohman EM, Chen AY, Wang TY, Peterson ED, Roe MT, Holper EM; CRUSADE and ACTION Registry-GWTG Participants.

JACC Cardiovasc Interv. 2010 Apr;3(4):419-27. doi: 10.1016/j.jcin.2010.01.012.

6.

Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention.

Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF.

JACC Cardiovasc Interv. 2011 Sep;4(9):1002-8. doi: 10.1016/j.jcin.2011.05.022.

7.

Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience.

Pedrazzini GB, Radovanovic D, Vassalli G, Sürder D, Moccetti T, Eberli F, Urban P, Windecker S, Rickli H, Erne P; AMIS Plus Investigators.

JACC Cardiovasc Interv. 2011 Jun;4(6):627-33. doi: 10.1016/j.jcin.2011.04.004.

8.

Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR Jr, O'Neill WW, Hamm CW, Van de Werf F, Armstrong PW; APEX AMI Investigators.

JACC Cardiovasc Interv. 2010 Mar;3(3):343-51. doi: 10.1016/j.jcin.2009.12.008.

9.

Impact of day versus night as intervention time on the outcomes of primary angioplasty for acute myocardial infarction.

Uyarel H, Ergelen M, Akkaya E, Ayhan E, Demirci D, Gul M, Isik T, Cicek G, Gunaydin ZY, Ugur M, Demirci DE, Turkkan C, Erer HB, Ozturk R, Yekeler I.

Catheter Cardiovasc Interv. 2009 Nov 15;74(6):826-34. doi: 10.1002/ccd.22154.

PMID:
19670313
10.

Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy).

Cubeddu RJ, Palacios IF, Blankenship JC, Horvath SA, Xu K, Kovacic JC, Dangas GD, Witzenbichler B, Guagliumi G, Kornowski R, Dudek D, Stone GW, Mehran R.

Am J Cardiol. 2013 Apr 1;111(7):946-54. doi: 10.1016/j.amjcard.2012.11.062. Epub 2013 Jan 19.

PMID:
23340031
11.

Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.

Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB 3rd.

JACC Cardiovasc Interv. 2010 Jan;3(1):22-31. doi: 10.1016/j.jcin.2009.10.017.

12.

Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.

Lee HW, Hong TJ, Yang MJ, An SG, Oh JH, Choi JH, Lee HC, Cha KS, Hong JY; Korea Acute Myocardial Infarction Registry Investigators.

Cardiol J. 2012;19(3):256-66.

13.

Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.

Denktas AE, Athar H, Henry TD, Larson DM, Simons M, Chan RS, Niles NW, Thiele H, Schuler G, Ahn C, Sdringola S, Anderson HV, McKay RG, Smalling RW.

JACC Cardiovasc Interv. 2008 Oct;1(5):504-10. doi: 10.1016/j.jcin.2008.06.009.

14.

Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial.

Mehta RH, Kaul P, Lopes RD, Patel MR, Zheng Y, Pieper KS, Welsh RC, Armstrong PW, Granger CB.

Am Heart J. 2012 May;163(5):797-803. doi: 10.1016/j.ahj.2012.03.001.

PMID:
22607857
15.

Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.

Mehta RH, Ou FS, Peterson ED, Shaw RE, Hillegass WB Jr, Rumsfeld JS, Roe MT; American College of Cardiology-National Cardiovascular Database Registry Investigators.

JACC Cardiovasc Interv. 2009 Jan;2(1):56-64. doi: 10.1016/j.jcin.2008.10.006.

16.

In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty.

Tespili M, Guagliumi G, Valsecchi O, Musumeci G, Vassileva A, Saino A, Scuri PM, Gavazzi A.

Ital Heart J. 2003 Mar;4(3):193-8.

PMID:
12784746
17.

The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.

Hussain F, Philipp RK, Ducas RA, Elliott J, Džavík V, Jassal DS, Tam JW, Roberts D, Garber PJ, Ducas J.

Catheter Cardiovasc Interv. 2011 Oct 1;78(4):540-8. doi: 10.1002/ccd.23006. Epub 2011 May 5.

PMID:
21547996
18.

A comparison of direct versus conventional stenting in patients undergoing primary angioplasty for ST-elevation myocardial infarction.

Isik T, Ayhan E, Uyarel H, Ergelen M, Cicek G, Osmonov D, Turkkan C, Turer A, Ghannadian B, Eren M.

Coron Artery Dis. 2012 Aug;23(5):348-53. doi: 10.1097/MCA.0b013e3283548862.

PMID:
22566098
19.

Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).

Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV.

Am J Cardiol. 2009 Aug 15;104(4):507-13. doi: 10.1016/j.amjcard.2009.04.016. Epub 2009 Jun 18.

PMID:
19660603
20.

Primary percutaneous coronary intervention without on-site cardiac surgery backup in unselected patients with ST-segment-elevation myocardial infarction: the Rivoli ST-segment elevation myocardial infarction (RISTEMI) registry.

Tomassini F, Gagnor A, Montali N, Infantino V, Tizzani E, Tizzani P, Lanza GA, Conte MR, Varbella F.

Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):9-13. doi: 10.1016/j.carrev.2012.11.004.

PMID:
23337379
Items per page

Supplemental Content

Write to the Help Desk